Bayer may halt EPDM project

Raleigh, Patrick
January 2002
European Rubber Journal;Jan2002, Vol. 184 Issue 1, p5
Trade Publication
Reports on the effort of Bayer AG to review the timing of a plan to increase its ethylene-propylene diene monomer (EPDM) capacity in Marl, Germany in 2002. Expansion at Bayer's other EPDM plant in Orange, Texas; Other companies that unveiled plans to establish facilities for two metallocene ethylene elastomers including EPDM in the U.S.


Related Articles

  • Bayer's Journey. Hunter, David // Chemical Week;2/6/2002, Vol. 164 Issue 5, p5 

    Provides information on Bayer AG in the United States as of February 6, 2002. Annual sales of the health care and crop protection business of Bayer; Value of Bayer's polymers business; Presentation of the top management during its New York Stock Exchange listing in January 2002.

  • Price fix fine sticks.  // Automotive Manufacturing Solutions;Nov/Dec2004, p14 

    Reports on the move by Bayer AG to settle conspiracy cases filed against the company at the U.S. District Court in San Francisco, California. Allegations that the company conspired to fix prices and suppress competition in the U.S. rubber market; Details of the settlement.

  • U.S. Firm to Set up $100 M Solar Plant in Karnataka.  // India -- West;1/15/2016, Vol. 41 Issue 9, pB6 

    No abstract available.

  • Bayer, the Good Neighbor.  // Pharmaceutical Executive;Oct2002, Vol. 22 Issue 10, p28 

    Reports the construction of the factory of Bayer AG in Elkhart, Indiana.

  • Bayer Plans $200-Million Plant at Kansas City. Westervelt, Robert // Chemical Week;1/12/2000, Vol. 162 Issue 2, p12 

    Focuses on Bayer company's plan to construct a pharmaceutical production plant at its Kansas City, Missouri site. Cost of the project; Pharmaceutical products to be produced in the plant; Expansion of the company's pharmaceutical operations in Connecticut.

  • Bayer Gears Up for $80 Million Expansion Of West Haven Plant.  // Chemical Market Reporter;10/04/99, Vol. 256 Issue 14, p18 

    Focuses on the plans of Bayer Group's North American pharmaceuticals business to expand its West Haven, Connecticut facility. Amount allocated for the expansion plans; Scope of the expansion plans; Deals of the company.

  • Bayer's U.S. effort. McN., M. // WWD: Women's Wear Daily;5/23/1995, Vol. 169 Issue 99, p10 

    Reports that Bayer has formally opened its new Dorlastan spandex plant in Bushy Park, S.C. in May 1995. Remarks by managing director and chief executive officer Klaus Schrewe on the decision to invest in the plant; Production of both opaque and transparent lusters in a full range of deniers;...

  • Corporations Behaving Badly: The Ten Worst Corporations of 2001.  // Multinational Monitor;Dec2001, Vol. 22 Issue 12, p8 

    Focuses on the different problems encountered by several companies in the United States in 2001. Criminal charges and civil liabilities paid by TAP Pharmaceuticals, a joint venture started by Abbott Laboratories and Takeda Pharmaceuticals; Account on the court case of airport security company...

  • Bayers builds oncology pipeline. KALTWASSER, JARED // njbiz;11/12/2012, p1 

    The article discusses the growing oncology product offerings of pharmaceutical firm Bayer AG. It mentions the participation of the firm in the June 2012 American Society of Clinical Oncology (ASCO) meeting to launch its cancer drug Stivarga. It is noted that this drug is the second oncology...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics